Trial Profile
AMPA receptor antagonist treatment of Parkinson's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Oct 2005
Price :
$35
*
At a glance
- Drugs Talampanel (Primary) ; Amantadine
- Indications Parkinson's disease
- Focus Therapeutic Use
- 26 Oct 2005 New trial record.